Physiology
Complete systems and individual components for physiology, pharmacology and toxicology experimentation and research.
harvardapparatus.comCrawled Nov 20, 2026
Complete systems and individual components for physiology, pharmacology and toxicology experimentation and research.
The company provides syringe, peristaltic, centrifugal, pulsatile, and continuous flow pumps and accessories for various applications.
Animal research products for basic and clinical psychopharmacology for study of brain functions, related pathologies, and discovery of new therapeutic compounds.
The company offers microdialysis instruments for long-term studies in freely moving small conscious animals.
Special offers and promotions from Harvard Apparatus.
Harvard Apparatus is a major US manufacturer of specialized physiological research laboratory equipment with current headquarters in Holliston, Massachusetts
Variability in artificial cerebrospinal fluid (aCSF) and electrophysiology buffers introduces inconsistencies that compromise data quality before experiments begin. Researchers using organoid and multiwell microelectrode array (MEA) workflows face reproducibility challenges due to these buffer inconsistencies, undermining reliable results in neuroscience studies.
Harvard Bioscience highlights how in-house preparation of artificial cerebrospinal fluid (aCSF) incurs hidden costs in neuroscience research. Time spent mixing batches, inconsistencies in formulation, and repeated experiments increase operational expenses. The company contrasts these challenges with the efficiency and reliability of ready-to-use aCSF solutions.
Harvard Apparatus introduces the **Pump 11 Pico Plus Elite** in a **single-channel configuration**, supporting syringe sizes from **0.5 µl to 60 ml**. The device retains the original dual-channel flow capabilities while enabling larger fluid volumes without syringe refills. The product expands the **Pump 11 Elite** family for precision fluid control in research applications.
Harvard Apparatus introduces the Pump 11 Elite glucose clamp infusion system, designed for academic studies requiring precise euglycemic or hyperglycemic glucose control. The device features a touchscreen interface for streamlined setup and built-in software to minimize fluid delivery errors. Its glucose clamp program aims to enhance efficiency in research protocols.
Harvard Apparatus launches a new line of **remote-controlled, programmable peristaltic pumps**. The company expands its fluid-handling solutions with advanced automation features for research and industrial applications.
Harvard Apparatus opens a liaison office in India to strengthen its global presence in the scientific instrument market. The move supports the company’s efforts to serve researchers and institutions in the region. No further details on operations or partnerships were provided.
Harvard Bioscience secures a court ruling affirming its right to use the *Harvard Apparatus* name after a trademark infringement lawsuit filed by Harvard University. The US District Court grants summary judgment in favor of the company, resolving the dispute over branding rights. Harvard Bioscience operates in life science research equipment and reagents.

Harvard Apparatus makes programmable syringe pumps, ventilators, blood pumps, and other specialized bioscience research products.